Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
SlideShare a Scribd company logo
Bringing the
Full Power of Science
to Bear on
Drug Abuse
& Addiction
Homelessness
Crime
Violence
Neurotoxicity
AIDS, Cancer
Mental illness
Health care
Productivity
Accidents
4 Out of 10 U.S. AIDS Deaths Are
Related to Drug Abuse
Estimated Economic Cost to Society
Due to Substance
Abuse and Addiction:
Illegal drugs: $181 billion/year
Alcohol: $185 billion/year
Tobacco: $158 billion/year
Total: $524 billion/year
Surgeon General’s Report, 2004; ONDCP, 2004; Harwood, 2000.
What is Addiction?
Addiction is A Brain Disease
• Characterized by:
– Compulsive Behavior
– Continued abuse of drugs despite negative consequences
– Persistent changes in the brain’s structure and function
Advances in science have
revolutionized our fundamental
views of drug abuse and addiction.
Your Brain on Drugs in the 1980’s
Your Brain on Drugs Today
YELLOW
shows places in
brain where
cocaine binds
(e.g., striatum)
Fowler et al., Synapse, 1989.
Addiction is Like Other Diseases…
 It is preventable
 It is treatable
 It changes biology
 If untreated, it can last a lifetime
Healthy Brain Diseased Heart
Decreased Heart Metabolism
in Heart Disease Patient
Decreased Brain Metabolism
in Drug Abuser
Diseased Brain/
Cocaine Abuser
Healthy
Heart
High
Low
Research supported by NIDA addresses all of these
components of addiction.
Addiction Involves Multiple Factors
National Epidemiologic Survey on Alcohol and Related Conditions, 2003.
Age
0.0%
0.0%
0.2%
0.2%
0.4%
0.4%
0.6%
0.6%
0.8%
0.8%
1.0%
1.0%
1.2%
1.2%
1.4%
1.4%
1.6%
1.6%
1.8%
1.8%
5
5 10
10 15
15 21
21 25
25 30
30 35
35 40
40 45
45 50
50 55
55 60
60 65
65
%
in
each
age
group
who
develop
first-time
dependence
CANNABIS
ALCOHOL
TOBACCO
Addiction Is A Developmental Disease
that starts in adolescence and childhood
Age at tobacco, alcohol, and cannabis dependence per DSM IV
Why Do People Take Drugs in The
First Place?
To Feel Good
To have novel:
feelings
sensations
experiences
AND
to share them
To Feel Better
To lessen:
anxiety
worries
fears
depression
hopelessness
Drugs of Abuse
Engage Motivation and
Pleasure Pathways
of the Brain
Why Do People
Abuse Drugs?
Drugs can be “Imposters” of
Brain Messages
Addiction Reward & well-being
Motivation
Movement
Dopamine
Donald Bliss, MAPB, Medical Illustration
The Neuron: How the Brain’s
Messaging System Works
Terminal
branches of
axon
Cell body
(the cell’s life
support
center)
Dendrites
Myelin
sheath
Axon
Neuronal Impulse
Neurobiology of drug abuse and addiction_NIDA
dopamine
transporters
Di Chiara et al., Neuroscience, 1999.,Fiorino and Phillips, J. Neuroscience, 1997.
Natural Rewards Elevate
Dopamine Levels
0
50
100
150
200
0 60 120 180
Time (min)
%
of
Basal
DA
Output
NAc shell
Empty
Food Sex
Box Feeding
100
150
200
DA
Concentration
(%
Baseline)
Sample
Number
1 2 3 4 5 6 7 8
Female Present
Neurobiology of drug abuse and addiction_NIDA
0
100
200
300
400
500
600
700
800
900
1000
1100
0 1 2 3 4 5 hr
%
of
Basal
Release
DA
DOPAC
HVA
Accumbens
Amphetamine
0
100
200
300
400
0 1 2 3 4 5 hr
%
of
Basal
Release
DA
DOPAC
HVA
Accumbens
Cocaine
Time After Drug
Morphine
0
100
150
200
250
0 1 2 3 hr
Time After Drug
%
of
Basal
Release
Accumbens
Caudate
Nicotine
Di Chiara and Imperato, PNAS, 1988
Effects of Drugs on Dopamine Release
%
of
Basal
Release
0
100
150
200
250
0 1 2 3 4 5 hr
Accumbens
0.5
1.0
2.5
10
Dose
mg/kg
mg/kg
mg/kg
mg/kg
But Dopamine is only Part of the Story
• Scientific research has shown that other
neurotransmitter systems are also affected:
–Serotonin
–Regulates mood, sleep, etc.
–Glutamate
–Regulates learning and memory, etc.
Neurobiology of drug abuse and addiction_NIDA
Prolonged Drug Use Changes
the Brain In Fundamental
and Long-Lasting Ways
Science Has Generated Much
Evidence Showing That…
We Have Evidence That
These Changes Can Be Both
Structural and Functional
AND…
Amph
Neuronal Dendrites in the
Nucleus Accumbens
Saline
Robinson & Kolb, Journal of Neuroscience, Volume: 1997
Structurally…
Control Addicted
Dopamine D2 Receptors are Decreased by Addiction
Functionally…
Cocaine
Alcohol
Heroin
Meth
Dopamine Transporters in Methamphetamine Abusers
Normal Control
Methamphetamine Abuser
Motor Task
Loss of dopamine
transporters in
methamphetamine
abusers may result in
slowing of motor
reactions.
Memory Task
Loss of dopamine
transporters in
methamphetamine
abusers may result
in memory impairment.
7 8 9 10 11 12 13
1.0
1.2
1.4
1.6
1.8
2.0
Time Gait
(seconds)
4
6
8
10
12
14
16
1.0
1.2
1.4
1.6
1.8
2.0
Delayed Recall
(words remembered)
Dopamine
Transporter
Bmax/Kd
Volkow et al., Am. J. Psychiatry, 2001.
Implication?
Brain changes resulting from
prolonged use of drugs
may compromise
mental AND motor function.
Circuits Involved In Drug Abuse and Addiction
All of these brain regions must be considered in developing
strategies to effectively treat addiction
Prevention Research (Children & Adolescents)
genetics
environment
development
co-morbidity
Priority Areas for NIDA
Treatment Research
(New Targets & New Strategies)
HIV/AIDS Research
Addiction is a Developmental Disease:
It Starts Early
1
10
100
Child Teen Young Adult Adult
67%
1.5%
5.5%
<12 12-17 18-25 >25
26%
Basic Science Tells Us that
Adolescents’ Brains
Are Still Developing…
Copyright ©2004 by the National Academy of Sciences Gogtay, Giedd, et al. Proc. Natl. Acad. Sci., 2004
MRI Scans of Healthy
Children and Teens Over Time
When Reading Emotion…
Adults Rely More on the Frontal Cortex
While Teens Rely More on the Amygdala
Deborah Yurgelon-Todd 2000.
Do Adolescents React Differently
than Adults to
Substances of Abuse?
Rats Exposed to Nicotine in Adolescence
Self-Administer More Nicotine
Than Rats First Exposed as Adults
Collins et al, Neuropharmacology, 2004, Levin et al, Psychopharmacology, 2003
Do We Need Fundamentally
Different Strategies At
Different Stages of Adolescence?
Why do some people
become addicted to drugs
while others do not?
Vulnerability
high
low
High DA
receptor
Low DA receptor
Individual Differences in Response to
Drugs: DA Receptors influence drug liking
As a group, subjects with low receptor levels found MP pleasant while those
with high levels found MP unpleasant
Adapted from Volkow et al., Am. J. Psychiatry, 1999.
Genetics is a Big Contributor to the
Risk of Addiction…
And…
The Nature of this Contribution
Is Extremely Complex
Gene Cluster is Associated with Nicotine
Dependence
What Other Biological Factors
Contribute to Addiction--Comorbidity
Prevalence of Drug Disorders
Percent
Prevalence of
Nicotine Addiction
0
20
40
60
80
Percent
0
5
10
15
20
25
30
35
40
COMORBIDITY
Why do Mental Illnesses and
Substance Abuse Co-occur?
• Self-medication
– substance abuse begins as a
means to alleviate symptoms of
mental illness
• Causal effects
– Substance abuse may increase
vulnerability to mental illness
• Common or correlated causes
– the risk factors that give rise to
mental illness and substance
abuse may be related or overlap
What Environmental
Factors Contribute to Addiction?
• Stress
• Early physical or sexual abuse
• Witnessing violence
• Peers who use drugs
• Drug availability
Becomes Subordinate
Stress remains
Becomes Dominant
No longer stressed
Individually
Housed
Group
Housed
Social Stressor Affects Brain DA D2
Receptors and Drug Self-Administration
Morgan, D. et al., Nature Neuroscience, 2002.
Cocaine (mg/kg/injection)
*
*
S.003 .01 .03 .1
0
10
20
30
40
50
Dominant
Subordinate
Prevention Works:
Knowledge of Risk and Protective
Factors Has Led to the
Development of Effective
Prevention Strategies
Changes in Attitudes Lead to
Changes in Use
0
10
20
30
40
50
60
75 77 79 81 83 85 87 89 91 93 95 97 99 01 03 05 07
Past Year Use Perceived Risk
Monitoring the Future Study, 2007.
Treatment Research
(New Targets & New Strategies)
Prevention Research (Children & Adolescents)
genetics
environment
development
co-morbidity
HIV/AIDS Research
Priority Areas for NIDA
Adapted from Volkow et al., Neuropharmacology, 2004.
Drive
Saliency
Memory
Control
Non-Addicted Brain
NO
GO
Addicted Brain
Drive
Memory
Control
GO
Saliency
Why Can’t Addicts Just Quit?
Because Addiction Changes Brain Circuits
This is why treatment is essential.
This is why addicts can’t just quit.
and…
Treating a Biobehavioral Disorder Must Go
Beyond Just Fixing the Chemistry
Pharmacological
Treatments
(Medications)
We Need to Treat the
Whole Person!
In Social Context
Behavioral Therapies
Social Services
Medical Services
• No single treatment is appropriate for all
individuals.
• Treatment needs to be readily available.
• Treatment must attend to multiple needs of
the individual, not just drug use.
• Multiple courses of treatment may be
required for success.
• Remaining in treatment for an adequate
period of time is critical for treatment
effectiveness.
Treatment Can Work!
NIDA’s Principles of Treatment
We Are Using Science to
Develop Even Better Treatments
Genetics Mechanisms Treatments
CB1 Antagonists
Inhibitors of
metabolizing enzymes
CRF Antagonists
Medication
Basic Research
Agonist Therapy
Methadone
Buprenorphine
Opiate agonists stabilize brain
function in heroin addicts
CB1 KO mice have decreased
responses to multiple drugs of abuse
Smokers who are poor nicotine
metabolizers smoke less
Stress triggers relapse in animal models
of addiction and CRF antagonists
interfere with the response to stress
But, drug addiction is a chronic illness
with relapse rates similar to those of
hypertension, diabetes, and asthma.
McLellan et al., JAMA, 2000.
Relapse Rates Are Similar for Drug
Addiction & Other Chronic Illnesses
Type I
Diabetes
Drug
Addiction
0
10
20
30
40
50
60
70
80
90
100
Hypertension Asthma
40
to
60%
30
to
50%
50
to
70%
50
to
70%
Percent
of
Patients
Who
Relapse
McLellan et al., JAMA, 2000.
Addiction is Similar to Other
Chronic Illnesses Because:
• It has biological and behavioral components, both of which must be
addressed during treatment.
• Recovery from it--protracted abstinence and restored functioning--is often a
long-term process requiring repeated episodes of treatment.
• Relapses can occur during or after treatment, and signal a need for
treatment adjustment or reinstatement.
• Participation in support programs during and following treatment can be
helpful in sustaining long-term recovery
Therefore…
Full recovery is a challenge
but it is possible …
Extended Abstinence
is Predictive of Sustained Recovery
It takes a year
of abstinence
before less than
half relapse
Dennis et al, Eval Rev, 2007
After 5 years – if you are sober,
you probably will stay that way.
DAT Recovery
with prolonged
abstinence from
methamphetamine
[C-11]d-threo-methylphenidate
Volkow et al., J. Neuroscience, 2001.
low
high
Normal Control
Methamphetamine Abuser
(1 month abstinent)
Methamphetamine Abuser
(14 months abstinent)
Treatment Reduces
Drug Use and Recidivism
Delaware Work Release Therapeutic Community (CREST) + Aftercare
3 Years After Release (N=448)
p < 0.05,
compared to no treatment group
Percentage
of
Participants
We Need to Keep Our Eye on
the Real Targets!
In Treating Addiction…
Treatment Research
(New Targets & New Strategies)
Prevention Research (Children & Adolescents)
genetics
environment
development
co-morbidity
HIV/AIDS Research
Priority Areas for NIDA
Drug Use Has Played a Prominent
Role in the HIV/AIDS Epidemic
In Several Ways
• Disease Transmission
- IV Drug Use—Needle sharing
- Drug Intoxication: Impaired judgment,
disinhibition, leading to risky sexual
behaviors
• Disease Progression
• Neurological Complications
Proportions of AIDS Cases in Adults & Adolescents by
Exposure in the USA
Centers for Disease Control and Prevention (CDC)
Men who have sex with men (MSM)
Injection drug use
MSM who inject drugs
Year of Diagnosis
%
of
Cases
70
60
50
40
30
20
10
0
1985 1987 1989 1991 1993 1995 1997 1999 2001 2003
Drugs of Abuse Have Had A Major Impact
on the HIV/AIDS Epidemic
Heterosexual contact
Convergence of HIV Seroprevalence Among
Injecting and Non-injecting Drug Users
0
5
10
15
20
Current Injectors Non-Injectors
HIV
Prevalence
13%
CI 12-15%
12%
CI 9-16%
Drug Treatment Program
(n=2121 2001-2004)
Respondent-Driven Sampling
(n=448 2004)
0
5
10
15
20
15%
CI 11-19%
17%
CI 12-21%
Source: Des Jarlais et al AIDS, 21: 231-235, 2007.
Current Injectors Non-Injectors
White, not Hispanic
Black, not Hispanic
Hispanic
Asian/Pacific Islander American Indian/
Alaska Native
Year of Diagnosis
%
of
Cases
70
60
50
40
30
20
10
0
Centers for Disease Control and Prevention (CDC)
The AIDS Epidemic Disproportionately
Affects Minority Populations
1985 1987 1989 1991 1993 1995 1997 1999 2001 2003 2005
Acceleration of HIV Degeneration of
Dopamine Cells With Cocaine
International
Research
Collaboration
NIDA International
Program Components
Post-Doctoral Research Fellowship
Technical
Consultation
Scientific
Exchange
Information Dissemination
Why focus on drug abuse
internationally?
I. Drug abuse is a global phenomenon
5 % of people aged 15-64
II. Intertwined dual-epidemics of drug
addiction & HIV/AIDS
HIV Infections Attributed to
Injection Drug Use and Risky
Sexual Behaviors Related to
Drug Abuse
Millions of Users
160.9
26.2
13.7
15.9
7.9 Cannabis
Amphetamines
Ecstasy
Cocaine
Opiates
UNODC 2005 World Drug Report
III. Take advantage of unique opportunities to advance scientific knowledge
through research
NIDA Supports International Drug Abuse
Research In Numerous Ways
Fund international research
Provide training and exchange opportunities
Set international research priorities
Organize & sponsor conferences and meetings
Binational agreements
Dissemination of information
Where Do We Need
to Go From Here?
We Need to…
Advance the SCIENCE
Erase the STIGMA
and…
Erase the STIGMA
and…
For More Information
NIDA Public Information:
www.nida.nih.gov
www.drugabuse.gov
NIDA International Program:
www.international.drugabuse.gov
www.drugabuse.gov NIDANATIONAL INSTITUTE
ON DRUG ABUSE

More Related Content

Neurobiology of drug abuse and addiction_NIDA

  • 1. Bringing the Full Power of Science to Bear on Drug Abuse & Addiction
  • 3. 4 Out of 10 U.S. AIDS Deaths Are Related to Drug Abuse
  • 4. Estimated Economic Cost to Society Due to Substance Abuse and Addiction: Illegal drugs: $181 billion/year Alcohol: $185 billion/year Tobacco: $158 billion/year Total: $524 billion/year Surgeon General’s Report, 2004; ONDCP, 2004; Harwood, 2000.
  • 5. What is Addiction? Addiction is A Brain Disease • Characterized by: – Compulsive Behavior – Continued abuse of drugs despite negative consequences – Persistent changes in the brain’s structure and function
  • 6. Advances in science have revolutionized our fundamental views of drug abuse and addiction.
  • 7. Your Brain on Drugs in the 1980’s
  • 8. Your Brain on Drugs Today YELLOW shows places in brain where cocaine binds (e.g., striatum) Fowler et al., Synapse, 1989.
  • 9. Addiction is Like Other Diseases…  It is preventable  It is treatable  It changes biology  If untreated, it can last a lifetime Healthy Brain Diseased Heart Decreased Heart Metabolism in Heart Disease Patient Decreased Brain Metabolism in Drug Abuser Diseased Brain/ Cocaine Abuser Healthy Heart High Low Research supported by NIDA addresses all of these components of addiction.
  • 11. National Epidemiologic Survey on Alcohol and Related Conditions, 2003. Age 0.0% 0.0% 0.2% 0.2% 0.4% 0.4% 0.6% 0.6% 0.8% 0.8% 1.0% 1.0% 1.2% 1.2% 1.4% 1.4% 1.6% 1.6% 1.8% 1.8% 5 5 10 10 15 15 21 21 25 25 30 30 35 35 40 40 45 45 50 50 55 55 60 60 65 65 % in each age group who develop first-time dependence CANNABIS ALCOHOL TOBACCO Addiction Is A Developmental Disease that starts in adolescence and childhood Age at tobacco, alcohol, and cannabis dependence per DSM IV
  • 12. Why Do People Take Drugs in The First Place? To Feel Good To have novel: feelings sensations experiences AND to share them To Feel Better To lessen: anxiety worries fears depression hopelessness
  • 13. Drugs of Abuse Engage Motivation and Pleasure Pathways of the Brain Why Do People Abuse Drugs?
  • 14. Drugs can be “Imposters” of Brain Messages
  • 15. Addiction Reward & well-being Motivation Movement Dopamine
  • 16. Donald Bliss, MAPB, Medical Illustration The Neuron: How the Brain’s Messaging System Works Terminal branches of axon Cell body (the cell’s life support center) Dendrites Myelin sheath Axon Neuronal Impulse
  • 19. Di Chiara et al., Neuroscience, 1999.,Fiorino and Phillips, J. Neuroscience, 1997. Natural Rewards Elevate Dopamine Levels 0 50 100 150 200 0 60 120 180 Time (min) % of Basal DA Output NAc shell Empty Food Sex Box Feeding 100 150 200 DA Concentration (% Baseline) Sample Number 1 2 3 4 5 6 7 8 Female Present
  • 21. 0 100 200 300 400 500 600 700 800 900 1000 1100 0 1 2 3 4 5 hr % of Basal Release DA DOPAC HVA Accumbens Amphetamine 0 100 200 300 400 0 1 2 3 4 5 hr % of Basal Release DA DOPAC HVA Accumbens Cocaine Time After Drug Morphine 0 100 150 200 250 0 1 2 3 hr Time After Drug % of Basal Release Accumbens Caudate Nicotine Di Chiara and Imperato, PNAS, 1988 Effects of Drugs on Dopamine Release % of Basal Release 0 100 150 200 250 0 1 2 3 4 5 hr Accumbens 0.5 1.0 2.5 10 Dose mg/kg mg/kg mg/kg mg/kg
  • 22. But Dopamine is only Part of the Story • Scientific research has shown that other neurotransmitter systems are also affected: –Serotonin –Regulates mood, sleep, etc. –Glutamate –Regulates learning and memory, etc.
  • 24. Prolonged Drug Use Changes the Brain In Fundamental and Long-Lasting Ways Science Has Generated Much Evidence Showing That…
  • 25. We Have Evidence That These Changes Can Be Both Structural and Functional AND…
  • 26. Amph Neuronal Dendrites in the Nucleus Accumbens Saline Robinson & Kolb, Journal of Neuroscience, Volume: 1997 Structurally…
  • 27. Control Addicted Dopamine D2 Receptors are Decreased by Addiction Functionally… Cocaine Alcohol Heroin Meth
  • 28. Dopamine Transporters in Methamphetamine Abusers Normal Control Methamphetamine Abuser Motor Task Loss of dopamine transporters in methamphetamine abusers may result in slowing of motor reactions. Memory Task Loss of dopamine transporters in methamphetamine abusers may result in memory impairment. 7 8 9 10 11 12 13 1.0 1.2 1.4 1.6 1.8 2.0 Time Gait (seconds) 4 6 8 10 12 14 16 1.0 1.2 1.4 1.6 1.8 2.0 Delayed Recall (words remembered) Dopamine Transporter Bmax/Kd Volkow et al., Am. J. Psychiatry, 2001.
  • 29. Implication? Brain changes resulting from prolonged use of drugs may compromise mental AND motor function.
  • 30. Circuits Involved In Drug Abuse and Addiction All of these brain regions must be considered in developing strategies to effectively treat addiction
  • 31. Prevention Research (Children & Adolescents) genetics environment development co-morbidity Priority Areas for NIDA Treatment Research (New Targets & New Strategies) HIV/AIDS Research
  • 32. Addiction is a Developmental Disease: It Starts Early 1 10 100 Child Teen Young Adult Adult 67% 1.5% 5.5% <12 12-17 18-25 >25 26%
  • 33. Basic Science Tells Us that Adolescents’ Brains Are Still Developing…
  • 34. Copyright ©2004 by the National Academy of Sciences Gogtay, Giedd, et al. Proc. Natl. Acad. Sci., 2004 MRI Scans of Healthy Children and Teens Over Time
  • 35. When Reading Emotion… Adults Rely More on the Frontal Cortex While Teens Rely More on the Amygdala Deborah Yurgelon-Todd 2000.
  • 36. Do Adolescents React Differently than Adults to Substances of Abuse?
  • 37. Rats Exposed to Nicotine in Adolescence Self-Administer More Nicotine Than Rats First Exposed as Adults Collins et al, Neuropharmacology, 2004, Levin et al, Psychopharmacology, 2003
  • 38. Do We Need Fundamentally Different Strategies At Different Stages of Adolescence?
  • 39. Why do some people become addicted to drugs while others do not? Vulnerability
  • 40. high low High DA receptor Low DA receptor Individual Differences in Response to Drugs: DA Receptors influence drug liking As a group, subjects with low receptor levels found MP pleasant while those with high levels found MP unpleasant Adapted from Volkow et al., Am. J. Psychiatry, 1999.
  • 41. Genetics is a Big Contributor to the Risk of Addiction… And… The Nature of this Contribution Is Extremely Complex
  • 42. Gene Cluster is Associated with Nicotine Dependence
  • 43. What Other Biological Factors Contribute to Addiction--Comorbidity Prevalence of Drug Disorders Percent Prevalence of Nicotine Addiction 0 20 40 60 80 Percent 0 5 10 15 20 25 30 35 40
  • 45. Why do Mental Illnesses and Substance Abuse Co-occur? • Self-medication – substance abuse begins as a means to alleviate symptoms of mental illness • Causal effects – Substance abuse may increase vulnerability to mental illness • Common or correlated causes – the risk factors that give rise to mental illness and substance abuse may be related or overlap
  • 46. What Environmental Factors Contribute to Addiction? • Stress • Early physical or sexual abuse • Witnessing violence • Peers who use drugs • Drug availability
  • 47. Becomes Subordinate Stress remains Becomes Dominant No longer stressed Individually Housed Group Housed Social Stressor Affects Brain DA D2 Receptors and Drug Self-Administration Morgan, D. et al., Nature Neuroscience, 2002. Cocaine (mg/kg/injection) * * S.003 .01 .03 .1 0 10 20 30 40 50 Dominant Subordinate
  • 48. Prevention Works: Knowledge of Risk and Protective Factors Has Led to the Development of Effective Prevention Strategies
  • 49. Changes in Attitudes Lead to Changes in Use 0 10 20 30 40 50 60 75 77 79 81 83 85 87 89 91 93 95 97 99 01 03 05 07 Past Year Use Perceived Risk Monitoring the Future Study, 2007.
  • 50. Treatment Research (New Targets & New Strategies) Prevention Research (Children & Adolescents) genetics environment development co-morbidity HIV/AIDS Research Priority Areas for NIDA
  • 51. Adapted from Volkow et al., Neuropharmacology, 2004. Drive Saliency Memory Control Non-Addicted Brain NO GO Addicted Brain Drive Memory Control GO Saliency Why Can’t Addicts Just Quit? Because Addiction Changes Brain Circuits
  • 52. This is why treatment is essential. This is why addicts can’t just quit. and…
  • 53. Treating a Biobehavioral Disorder Must Go Beyond Just Fixing the Chemistry Pharmacological Treatments (Medications) We Need to Treat the Whole Person! In Social Context Behavioral Therapies Social Services Medical Services
  • 54. • No single treatment is appropriate for all individuals. • Treatment needs to be readily available. • Treatment must attend to multiple needs of the individual, not just drug use. • Multiple courses of treatment may be required for success. • Remaining in treatment for an adequate period of time is critical for treatment effectiveness. Treatment Can Work! NIDA’s Principles of Treatment
  • 55. We Are Using Science to Develop Even Better Treatments Genetics Mechanisms Treatments
  • 56. CB1 Antagonists Inhibitors of metabolizing enzymes CRF Antagonists Medication Basic Research Agonist Therapy Methadone Buprenorphine Opiate agonists stabilize brain function in heroin addicts CB1 KO mice have decreased responses to multiple drugs of abuse Smokers who are poor nicotine metabolizers smoke less Stress triggers relapse in animal models of addiction and CRF antagonists interfere with the response to stress
  • 57. But, drug addiction is a chronic illness with relapse rates similar to those of hypertension, diabetes, and asthma. McLellan et al., JAMA, 2000.
  • 58. Relapse Rates Are Similar for Drug Addiction & Other Chronic Illnesses Type I Diabetes Drug Addiction 0 10 20 30 40 50 60 70 80 90 100 Hypertension Asthma 40 to 60% 30 to 50% 50 to 70% 50 to 70% Percent of Patients Who Relapse McLellan et al., JAMA, 2000.
  • 59. Addiction is Similar to Other Chronic Illnesses Because: • It has biological and behavioral components, both of which must be addressed during treatment. • Recovery from it--protracted abstinence and restored functioning--is often a long-term process requiring repeated episodes of treatment. • Relapses can occur during or after treatment, and signal a need for treatment adjustment or reinstatement. • Participation in support programs during and following treatment can be helpful in sustaining long-term recovery Therefore…
  • 60. Full recovery is a challenge but it is possible …
  • 61. Extended Abstinence is Predictive of Sustained Recovery It takes a year of abstinence before less than half relapse Dennis et al, Eval Rev, 2007 After 5 years – if you are sober, you probably will stay that way.
  • 62. DAT Recovery with prolonged abstinence from methamphetamine [C-11]d-threo-methylphenidate Volkow et al., J. Neuroscience, 2001. low high Normal Control Methamphetamine Abuser (1 month abstinent) Methamphetamine Abuser (14 months abstinent)
  • 63. Treatment Reduces Drug Use and Recidivism Delaware Work Release Therapeutic Community (CREST) + Aftercare 3 Years After Release (N=448) p < 0.05, compared to no treatment group Percentage of Participants
  • 64. We Need to Keep Our Eye on the Real Targets! In Treating Addiction…
  • 65. Treatment Research (New Targets & New Strategies) Prevention Research (Children & Adolescents) genetics environment development co-morbidity HIV/AIDS Research Priority Areas for NIDA
  • 66. Drug Use Has Played a Prominent Role in the HIV/AIDS Epidemic In Several Ways • Disease Transmission - IV Drug Use—Needle sharing - Drug Intoxication: Impaired judgment, disinhibition, leading to risky sexual behaviors • Disease Progression • Neurological Complications
  • 67. Proportions of AIDS Cases in Adults & Adolescents by Exposure in the USA Centers for Disease Control and Prevention (CDC) Men who have sex with men (MSM) Injection drug use MSM who inject drugs Year of Diagnosis % of Cases 70 60 50 40 30 20 10 0 1985 1987 1989 1991 1993 1995 1997 1999 2001 2003 Drugs of Abuse Have Had A Major Impact on the HIV/AIDS Epidemic Heterosexual contact
  • 68. Convergence of HIV Seroprevalence Among Injecting and Non-injecting Drug Users 0 5 10 15 20 Current Injectors Non-Injectors HIV Prevalence 13% CI 12-15% 12% CI 9-16% Drug Treatment Program (n=2121 2001-2004) Respondent-Driven Sampling (n=448 2004) 0 5 10 15 20 15% CI 11-19% 17% CI 12-21% Source: Des Jarlais et al AIDS, 21: 231-235, 2007. Current Injectors Non-Injectors
  • 69. White, not Hispanic Black, not Hispanic Hispanic Asian/Pacific Islander American Indian/ Alaska Native Year of Diagnosis % of Cases 70 60 50 40 30 20 10 0 Centers for Disease Control and Prevention (CDC) The AIDS Epidemic Disproportionately Affects Minority Populations 1985 1987 1989 1991 1993 1995 1997 1999 2001 2003 2005
  • 70. Acceleration of HIV Degeneration of Dopamine Cells With Cocaine
  • 71. International Research Collaboration NIDA International Program Components Post-Doctoral Research Fellowship Technical Consultation Scientific Exchange Information Dissemination
  • 72. Why focus on drug abuse internationally? I. Drug abuse is a global phenomenon 5 % of people aged 15-64 II. Intertwined dual-epidemics of drug addiction & HIV/AIDS HIV Infections Attributed to Injection Drug Use and Risky Sexual Behaviors Related to Drug Abuse Millions of Users 160.9 26.2 13.7 15.9 7.9 Cannabis Amphetamines Ecstasy Cocaine Opiates UNODC 2005 World Drug Report III. Take advantage of unique opportunities to advance scientific knowledge through research
  • 73. NIDA Supports International Drug Abuse Research In Numerous Ways Fund international research Provide training and exchange opportunities Set international research priorities Organize & sponsor conferences and meetings Binational agreements Dissemination of information
  • 74. Where Do We Need to Go From Here? We Need to… Advance the SCIENCE Erase the STIGMA and… Erase the STIGMA and…
  • 75. For More Information NIDA Public Information: www.nida.nih.gov www.drugabuse.gov NIDA International Program: www.international.drugabuse.gov www.drugabuse.gov NIDANATIONAL INSTITUTE ON DRUG ABUSE